Riociguat(CAS: 625115-55-1)

Riociguat (CAS: 625115-55-1) is a chemical compound primarily used in the treatment of pulmonary hypertension. It functions as a soluble guanylate cyclase (sGC) stimulator, enhancing the production of cyclic guanosine monophosphate (cGMP) to relax blood vessels and improve blood flow. Its chemical formula is C18H20N6O4S.

Riociguat (CAS: 625115-55-1) is mainly used in pharmaceutical applications to treat pulmonary hypertension. It is also used in research for studying cardiovascular diseases and as a tool in drug development for sGC activators. Its role in improving oxygenation and reducing pulmonary artery pressure makes it a key compound in therapeutic and scientific contexts.

Riociguat (CAS: 625115-55-1) is generally considered safe when used as directed in medical settings. However, it may cause side effects such as headaches, dizziness, and hypotension. Proper handling and adherence to safety guidelines are essential, especially in laboratory environments. Safety data sheets and regulatory approvals ensure its safe use in pharmaceutical and research applications.

Riociguat (CAS: 625115-55-1) should be stored in a cool, dry place away from direct light. It is typically kept in airtight containers to maintain its stability and prevent degradation. Storage conditions should be between 15°C to 25°C (59°F to 77°F) with low humidity to ensure optimal shelf life and potency.